Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets-Reference-Cited by-同舟云学术

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

Published:2020-04-10 Issue:7 Volume:39 Page:2055-2062
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Misra Durga Prasanna^ORCID,Agarwal Vikas^ORCID,Gasparyan Armen Yuri^ORCID,Zimba Olena^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05073-9.pdf

Reference61 articles.

1. COVID-19 cases worldwide. https://www.worldometers.info/coronavirus/. Accessed on 29 Mar 2020

2. Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032

3. Habibzadeh P, Stoneman EK (2020) The novel coronavirus: a Bird's eye view. Int J Occup Environ Med 11:65–71. https://doi.org/10.15171/ijoem.2020.1921

4. COVID-19 Situation report 68 by the World Health Organization. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200328-sitrep-68-covid-19.pdf?sfvrsn=384bc74c_2.2. Updated on 28 March 2020. Accessed on 29 Mar 2020

5. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G (2020) Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(20)30195-x

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system;Intelligent Pharmacy;2024-08

2. Early results of transnasal endoscopic nerve transfer for olfactory neuroepithelium stimulation;European Journal of Plastic Surgery;2024-06-04

3. Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases;Journal of Translational Autoimmunity;2024-06

4. A Review Article on Persistent Post -COVID Syndrome (PPCS);Asian Journal of Pharmacy and Technology;2024-03-04

5. Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID‐19 Patients;Journal of Immunology Research;2024-01